메뉴 건너뛰기




Volumn 14, Issue 11, 2013, Pages 951-954

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

EID: 84887108922     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2013.163     Document Type: Article
Times cited : (32)

References (3)
  • 1
    • 81255157431 scopus 로고    scopus 로고
    • Tackling antibiotic resistance
    • Bush K et al (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9: 894-896
    • (2011) Nat Rev Microbiol , vol.9 , pp. 894-896
    • Bush, K.1
  • 2
    • 70349895519 scopus 로고    scopus 로고
    • Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship
    • Roberts R et al (2009) Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 49: 1175-1184
    • (2009) Clin Infect Dis , vol.49 , pp. 1175-1184
    • Roberts, R.1
  • 3
    • 84879515171 scopus 로고    scopus 로고
    • Bacteriophage adhering to mucus provide a non-host-derived immunity
    • Barr JJ et al (2013) Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci USA 110: 10771-10776
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. 10771-10776
    • Barr, J.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.